SZSE Ticker: 000989

Jiuzhitang Co., Ltd

九芝堂股份有限公司

九芝堂

JZT

Listing Date: 2000-06-28

Board: Main Board - A Shares

Industry Classification: Manufacturing

A number of companies have clarified that "there is no fenugreek"! Beware of second-degree speculation in risk concept stocks_Sina Finance_Sina.com

Post date May 17, 2022 — 15:02 Post Lock

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation CFi.CN Zhongcai Network

Post date May 17, 2022 — 14:57 Post Lock

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation

Post date May 17, 2022 — 14:10 Post Lock

A number of companies have clarified that "there is no fenugreek"! Beware of the risk of second-degree speculation

Post date May 17, 2022 — 12:42 Post Lock

Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Teller Report

Post date May 16, 2022 — 21:51 Post Lock

Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research_Securities Times

Post date May 16, 2022 — 21:50 Post Lock

Jiuzhitang: Stem cell clinical trial project is conducting dose escalation research Finance and Economics

Post date May 16, 2022 — 21:50 Post Lock

Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years, Sales of Many Major Categories Decline

Post date May 13, 2022 — 11:03 Post Lock

Zhendong Pharmaceutical has received a letter of inquiry about the annual report for three consecutive years. The sale of its subsidiary has taken out Fangyuan Capital. Zhendong Pharmaceutical, Fangyuan Capital, Shenzhen Stock Exchange_Sina Technology_Sina.com

Post date May 13, 2022 — 08:55 Post Lock

Zhendong Pharmaceutical Receives Annual Report Inquiry Letters for Three Consecutive Years

Post date May 13, 2022 — 08:50 Post Lock

Yifeng Pharmacy was surveyed by 61 institutions: the company adopts the full retrospective method, the annual report has retrospectively adjusted the data in 2020, and the impact of the new standards on 2021 has been eliminated (with survey questions and answers)

Post date May 7, 2022 — 12:08 Post Lock

The late trading rose sharply, and the pharmaceutical sector once again became the "sweet pastry" of institutions under the high prosperity of the industry

Post date May 6, 2022 — 18:35 Post Lock

Yifeng Pharmacy's 2021 revenue and net profit growth slowed down, the acquisition of Jiuzhitang's pharmacy was questioned as a "distribution-style acquisition" Financial Channel Rongyi Information Network

Post date May 6, 2022 — 16:21 Post Lock

A-share lunch review: Shanghai index rose 1.11% in half a day, and the turnover of Ningde era exceeded 17 billion yuan

Post date May 5, 2022 — 11:56 Post Lock

Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball

Post date May 3, 2022 — 18:04 Post Lock

Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits grow steadily, and store expansion accelerates – yqqlm

Post date May 3, 2022 — 12:20 Post Lock

Kaiyuan Securities maintains a buy rating for Yifeng Pharmacy: Receivables and profits are growing steadily, and store expansion is accelerating.

Post date May 3, 2022 — 12:19 Post Lock

What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code)

Post date May 2, 2022 — 11:17 Post Lock

Is Dong E E Jiao a donkey or a horse or a mystery?

Post date April 30, 2022 — 18:50 Post Lock

Dong-E-Ejiao, to make amends after the sheep is gone

Post date April 29, 2022 — 19:23 Post Lock

Want to see more data? Registered subscribers can see all the data.